Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01836029
Title Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors VentiRx Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.